2003
DOI: 10.1016/s0014-2999(02)02732-2
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia–reperfusion injuries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
78
0
1

Year Published

2005
2005
2014
2014

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 101 publications
(89 citation statements)
references
References 36 publications
10
78
0
1
Order By: Relevance
“…Protective effects of NHE inhibitors by posttreatment have been shown in previous studies in cardiac ischemic model [2,19]. Our results suggest that the effect of sabiporide may be involved in the reperfusion period, and similar results have been previously shown [2].…”
Section: Fig 2 Effect Of Sabiporide On Intracellular Casupporting
confidence: 91%
“…Protective effects of NHE inhibitors by posttreatment have been shown in previous studies in cardiac ischemic model [2,19]. Our results suggest that the effect of sabiporide may be involved in the reperfusion period, and similar results have been previously shown [2].…”
Section: Fig 2 Effect Of Sabiporide On Intracellular Casupporting
confidence: 91%
“…Similar, positive effects of NCX inhibition were reported from isolated guinea pig papillary muscles and rat hearts (Anderson, 2002;Schafer et al, 2001;Wang et al, 2007). NCX inhibitors were shown to attenuate myocardial reperfusion injury using in vivo experimental models (Takahashi et al, 2003). Under normal conditions or during ischemia 1 mM SEA0400 had no apparent effect on AP configuration, but improved the recovery of action potentials after reperfusion (Acsai et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Preischaemic administration of cariporide significantly attenuated ischaemia/reperfusion induced arrhythmogenesis in a variety of in vitro and in vivo models [54] while its post-ischaemic administration, though reduced the incidence of VF and subsequent cardiac death, the effect on mortality was not significant [59,64,65]. Our results obtained by the pre-ischaemic application of cariporide reflect the high antiarrhythmic efficacy of the treatment, and strongly support the conclusions of similar studies [30][31][32][33].…”
Section: Nhe Inhibition (Cariporide Alone)supporting
confidence: 84%